Innate immune cells in breast cancer--from villains to heroes? (Q37905673)

25 August 2017

1 reference

title

Innate immune cells in breast cancer--from villains to heroes? (English)

1 reference

25 August 2017

2

Mikala Egeblad

0 references

author name string

Tim Kees

series ordinal

1

1 reference

25 August 2017

publication date

26 July 2011

1 reference

Journal of Mammary Gland Biology and Neoplasia

25 August 2017

published in

1 reference

25 August 2017

volume

16

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

189-203

1 reference

Recognition of microbial infection by Toll-like receptors

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophage polarization comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The liaison between apoptotic cells and macrophages--the end programs the beginning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Leukocytes in mammary development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Roles of the innate immune system in mammary gland remodeling during involution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The role of nitric oxide in innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Inflammation and cancer: breast cancer as a prototype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophage polarization in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The yin-yang of tumor-associated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Matrix crosslinking forces tumor progression by enhancing integrin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Pancreatic cancer: the role of pancreatic stellate cells in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Dynamic interplay between the collagen scaffold and tumor evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

In vitro differentiation of human monocytes. Monocytes cultured on glass are cytotoxic to tumor cells but monocytes cultured on collagen are not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

In vitro differentiation of human monocytes. Differences in monocyte phenotypes induced by cultivation on glass or on collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Innate apoptotic immunity: the calming touch of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Functional imaging of proteolysis: stromal and inflammatory cells increase tumor proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The macrophage growth factor CSF-1 in mammary gland development and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Stimulation of macrophages by mucins through a macrophage scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Selective MHC expression in tumours modulates adaptive and innate antitumour responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Murine NKG2D ligands: "double, double toil and trouble".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Natural killer cell education and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Toll-like receptors in inflammation, infection and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The 'kiss of death' by dendritic cells to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Nitric oxide and macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Following TRAIL's path in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Macrophages as mediators of tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The role of NKT cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Specificity in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

When MAGE meets RING: insights into biological functions of MAGE proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Epitope landscape in breast and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Zoledronic acid use in cancer patients: more than just supportive care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

A Dendritic Cell Population Generated by a Fusion of GM-CSF and IL-21 Induces Tumor-Antigen–Specific Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Dendritic Cell‐Based Immunotherapy for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

DNA alkylating therapy induces tumor regression through an HMGB1-mediated activation of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Regulatory T cells: a new frontier in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Targeted delivery of oligomannose-coated liposome to the omental micrometastasis by peritoneal macrophages from patients with gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Classification of chemotherapeutic agents based on their differential in vitro effects on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Intravital two-photon imaging: a versatile tool for dissecting the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9224-2

CD40 ligation and phagocytosis differently affect the differentiation of monocytes into dendritic cells.

21 January 2018

1 reference

12 December 2020

Tumor cytotoxicity of peritoneal macrophages and peripheral blood monocytes from patients with ovarian, endometrial, and cervical cancer

1 reference

12 December 2020

Generation of MUC1-stimulated mononuclear cells using optimized conditions

1 reference

12 December 2020

Intrapleural infusion of activated macrophages and gamma-interferon in malignant pleural mesothelioma: a phase II study

1 reference

12 December 2020

Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response

1 reference

12 December 2020

Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators

1 reference

12 December 2020

Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.

1 reference

12 December 2020

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

1 reference

12 December 2020

Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self

1 reference

12 December 2020

The NKT cell system: bridging innate and acquired immunity

1 reference

12 December 2020

Peritonitis-induced antitumor activity of peritoneal macrophages from uremic patients

1 reference

12 December 2020

Mannosylated liposomes for targeted vaccines delivery

1 reference

12 December 2020

alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity

1 reference

12 December 2020

Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system

1 reference

12 December 2020

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

1 reference

12 December 2020

Dr William Coley and tumour regression: a place in history or in the future

1 reference

12 December 2020

Developing an Effective Breast Cancer Vaccine

1 reference

12 December 2020

Macrophage activation switching: an asset for the resolution of inflammation

1 reference

12 December 2020

Tumor-induced immune dysfunction: the macrophage connection.

1 reference

12 December 2020

An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer

1 reference

12 December 2020

Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes

1 reference

12 December 2020

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

1 reference

12 December 2020

Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer

1 reference

12 December 2020

Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression

1 reference

12 December 2020

Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences

1 reference

12 December 2020

Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration

1 reference

12 December 2020

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

12 December 2020

Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation

1 reference

12 December 2020

Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome

1 reference

12 December 2020

Activation of tumoricidal properties in peripheral blood monocytes of patients with colorectal carcinoma

1 reference

12 December 2020

Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms

1 reference

12 December 2020

TGF-β1 and BRCA2 expression are associated with clinical factors in breast cancer.

1 reference

12 December 2020

Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma

1 reference

12 December 2020

Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer

1 reference

12 December 2020

10.1007/S10911-011-9224-2

Identifiers

DOI

1 reference

release_4cwwkcnvefcwvllebaasjbvmea

25 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4cwwkcnvefcwvllebaasjbvmea

24 November 2022

mapped directly with Wikidata item

1 reference